Molecular Cardiology Research Institute (MCRI)

Cardiac Biology Research Center

The central core mission of the Cardiac Biology Research Center (CBRC) investigators is to advance our understanding of fundamental mechanisms that regulate cardiac structure and function across multiple disease conditions including heart failure, acute myocardial infarction, pulmonary and systemic hypertension, hypertrophic cardiomyopathy, autonomic dysfunction, and arrhythmias. With advanced expertise in molecular cardiology, integrative physiology, molecular imaging, nanotechnology, biomedical engineering, and translational research, the CBRC studies novel signaling mechanisms that govern cardiomyocyte and non-myocyte cell populations. 

Labs

The Blanton Laboratory studies the signaling molecule PKGI-alpha and it’s role in cardiac remodling. The Chen Laboratory utilizes molecular imaging of cell death and survival processes, to elucidate novel cardiovascular pathophysiology, and to leverage the knowledge with nanotechnology to develop therapeutics. The Chin Laboratory focuses on the pathogenesis and treatment of inherited and acquired cardiomyopathies, with particular emphasis on Hypertrophic Cardiomyopathy and Barth Syndrome.  The Galper Laboratory studies the interaction between lipid metabolism and autonomic regulation. The Kapur Laboratory studies the role transforming growth factor beta family signaling in cardiac and renal remodeling.

Mission

In addition to fundamental discovery, a major objective of the CBRC is to translate these discoveries into novel therapeutic targets to limit the onset and progression of cardiovascular disease. The CBRC maintains a highly collaborative environment with rich areas of cross-pollination with the vascular biology research center and center for translational pharmacology and genomics. Strong relationships between the CBRC, the Surgical and Interventional Research Laboratories (SIRL), the Cardiovascular Biobank and the CardioVascular Center have accelerated translational of several fundamental discoveries into large animal models and subsequently into early phase clinical trials.

Use of technology for advancement

The CBRC employs a wide variety of cutting-edge technology and pioneering techniques to achieve its core mission of fundamental discovery. A central CBRC resource is the Mouse Physiology Core, which conducts advanced hemodynamic studies involving non-surgical univentricular and biventricular pressure-volume loop analysis, electrophysiologic mapping, univentricular and biventricular pacing, 3D and strain imaging echocardiography, murine cardiac magnetic resonance imaging, and isolated Langendorf cardiac preparations. The mouse core also performs multiple models of cardiac injury in mice including: thoracic and pulmonary artery banding, pharmacologically induced pulmonary and systemic hypertension, acute myocardial infarction, coronary ischemia-reperfusion injury, renal ischemia-reperfusion injury, unilateral ureteral obstruction, and arterio-vascular shunts.

The CBRC also maintains a rich library of transgenic mouse models for constitutive and inducible manipulation of genetic targets. In collaboration with the SIRL, the CBRC also studies large animal models of coronary ischemia-reperfusion injury and rapid unipolar or bipolar pacing. This unique resource provides investigators with full interventional or cardiac surgical capabilities to study the biologic impact of device-based approaches for heart failure including mechanical circulatory support devices. CBRC investigators have also developed techniques for isolation of atrial and ventricular myocytes, fibroblasts, and Purkinje cells and have expertise in in vitro ischemia-reperfusion injury, cyclic mechanical stretch and strain studies, and single-cell RNA-seq analysis. In summary, the fertile and nurturing environment of the CBRC enables investigators to focus on translating fundamental discoveries into novel therapeutic and diagnostic approaches for millions of individuals suffering from cardiovascular disease worldwide. 

Robert M. Blanton, Jr., MD

Robert M. Blanton, Jr., MD

Accepting New Patients

Title(s): Cardiologist; Investigator and Co-Director, Mouse Physiology Core Laboratory, Molecular Cardiology Research Institute; Associate Professor, Tufts University School of Medicine
Department(s): Medicine, CardioVascular Center, Cardiology
Appt. Phone: 617-636-2273
Fax #: 617-636-1444

General cardiology, preventive cardiology

View Full Profile

Howard H. Chen, PhD

Howard H. Chen, PhD

Title(s): Investigator, Molecular Cardiology Research Institute; Assistant Professor, Tufts University School of Medicine
Department(s): Molecular Cardiology Research Institute
Appt. Phone:
Fax #:

Molecular imaging of cell death and survival, cell energetics, fibrosis and inflammation, molecular mechanisms of cardiac pathophysiology, nanotechnology and novel therapeutics

View Full Profile

Michael T. Chin, MD, PhD

Michael T. Chin, MD, PhD

Title(s): Research Director, Hypertrophic Cardiomyopathy (HCM) Center and Research Institute, Molecular Cardiology Research Institute (MCRI), CardioVascular Center (CVC), and the Division of Cardiology; Professor, TUSM
Department(s): Medicine, CardioVascular Center, Cardiology
Appt. Phone: 617-636-8066
Fax #: 617-636-7175

Hypertrophic cardiomyopathy, cardiovascular disease

View Full Profile

Navin K. Kapur, MD, FAHA, FACC, FSCAI

Navin K. Kapur, MD, FAHA, FACC, FSCAI

Accepting New Patients

Title(s): Executive Director, The CardioVascular Center for Research and Innovation (CVCRI); Director, Acute Mechanical Circulatory Support Program; Director, Interventional Research Laboratories; Director of Cardiac Biology Research Center, Molecular Cardiology Research Institute (MCRI); Associate Professor, Tufts University School of Medicine
Department(s): Medicine, CardioVascular Center, Cardiology
Appt. Phone: 617-636-8252
Fax #: 617-636-5913

Interventional cardiology, advanced heart failure, mechanical circulatory support

View Full Profile

Molecular Cardiology Research Institute 20th Anniversary logo

20 years of discovery

For the past 20 years, the investigators and research teams of the Molecular Cardiology Research Institute (MCRI) have continually translated basic findings into new clinical strategies for the diagnosis and treatment of cardiovascular disease.

Learn about our discoveries